Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Development of glycan-targeted nanoparticles as a novel therapeutic opportunity for gastric cancer treatment

Fig. 4

STn-targeted nanoparticles reach sTn-expressing tumors in vivo. Radio thin-layer chromatogram of A 99mTc-non-targeted or B 99mTc-sTn-targeted NPs with acetone as mobile phase. The radiochemical purity (RCP) > 98%. C Schematic representation of the radiolabeling process followed by tail vein injection of NPs in mice. D Representative static small animal SPECT/CT images 1-h after injection of 37 MBq of 99mTc-non-targeted or 99mTc-sTn-targeted NPs in MKN45-ST6GalNAc-I tumor-bearing Balb/c nude mice. Images are displayed as representative SPECT/CT images of tumor. Standard uptake values (SUV) for tumors are shown. Semiquantitative data are shown as mean ± SEM from 3 individual experiments

Back to article page